Delivery Order HHSO100201600004I-HHSO10033003T

Award Date 5/1/17
Potential Completion Date 11/30/17
Potential Value $564K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $499,100 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC. The order is for pharmaceutical goods and services under the Pandemic Influenza Preparedness and Response 2016-2021 multiple award contract. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of products to U.S. government agencies including influenza and hepatitis...
This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the prime contractor Glaxosmithkline, LLC (doing business as Glaxosmithkline). The $977,025.74 fixed-price delivery order contract supports the Pandemic Influenza Preparedness and Response 2016-2021 program and is for the provision of pharmaceutical products and services related to disease prevention and treatment. Glaxosmithkline, a global...
This is a $533,988.00 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to the pharmaceutical company Glaxosmithkline, LLC. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 IDIQ, which provides for the acquisition of medical countermeasures for pandemic influenza preparedness and response efforts. The contract does not have a set-aside designation....
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The $15,769,590.00 contract is for commercial bulk lots, with no set-aside designation, and is part of the Pandemic Influenza Preparedness and Response 2016-2021 IDIQ contract. The...
This federal contract award from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) was issued to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, valued at $1,811,664.60, is a delivery order under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract....
This is a delivery order award to Glaxosmithkline, LLC under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery/indefinite quantity (IDIQ) contract with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The $2,812,228.00 fixed-price order is for the production of clinical lots of a CGMP (current good manufacturing practice) influenza vaccine. This supports the Acquisition of Medical...
This federal contract award is for the manufacture of one bulk lot of the antigen AS03 on behalf of the Department of Defense Defense Health Agency. The contract was awarded to Glaxosmithkline, LLC, a pharmaceutical company that has provided a range of pharmaceutical goods and services to U.S. government agencies through various federal contracts and grants. The $8,359,043 firm fixed price delivery order is issued under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite...
This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to GlaxoSmithKline, LLC, a pharmaceutical company, under the Pandemic Influenza Preparedness and Response 2012-2016 contract. The contract is for the production of non-GMP influenza vaccine plots at a firm fixed price of $149,412.00. The award supports ASPR's broader efforts for pandemic influenza preparedness and response, including disease...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, to procure $40,551,654.40 in products. The contract has no set-aside designation. Glaxosmithkline provides various pharmaceutical goods and services to multiple federal agencies, including vaccines, antiviral medications, and drug development support. This award was likely made under one of Glaxosmithkline's...

This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a set-aside designation. Glaxosmithkline's performance will occur at its facilities in Research Triangle Park, North Carolina. The company has received numerous federal contracts and grants to support disease prevention, immunization programs, drug stockpiling, and correctional healthcare services for agencies including the Departments of Defense, Veterans Affairs, State, and Justice.

Generated 3/23/24, 1:55 PM